Atlas Trials

The Optimal Dosage of Ropivacaine for Arthroscopic Knee Surgery

Clinical trial NCT04759742 · COMPLETED

Trial details

NCT number
NCT04759742
Sponsor
Yanchao Yang
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Arthroscopic Knee SurgeryRopivacaineCombined Spinal Epidurai AnesthesiaED50ED95
Start date
2021-03-01
Primary completion
2023-06-01
Enrollment
115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.